Novavax Inc (NVAX)
$6.11
0.13 (2.17%)
NVAX Stock Quote Delayed 30 Minutes
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
The vaccine stocks Pfizer, Moderna, and Novavax all have approved Covid-19 vaccines. They'll soon need new sources of revenue.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
455.10M
PE Ratio
-0.73
EPS
-8.42
Volume (Avg. Vol.)
2.90M
Day's Range
$5.92 - $6.36
52-Week Range
$5.68 - $85.37
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
Why Is Novavax (NVAX) Stock Down 26% Today?
Novavax (NVAX) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.
NVAX Stock Alert: What to Know as Novavax Names New CEO
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.
Three Pharma Stocks to Sell Before They Die
Small investors should not be venture capitalists, betting on companies before they have something to market, or a proven business model.
Why Is Novavax (NVAX) Stock Down 10% Today?
Novavax is conducting a public offering of 6.5 million shares. Here's why the news is pushing NVAX stock down.
Why Is Novavax (NVAX) Stock Plunging Today?
NVAX stock is down today on fundraising plans. Here's what investors should know about this once-promising Covid-19 vaccine player.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi
Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session.
What Is Going on With Novavax (NVAX) Stock Today?
Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19.
Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?
Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?
What Is Going on With Novavax (NVAX) Stock Today?
Despite a massive positive catalyst coming out of an FDA approval today, investors in NVAX stock are still seeing downside.
Why Is Novavax (NVAX) Stock in the Spotlight Today?
Novavax (NVAX) stock is on the move Wednesday following positive data from its Phase 3 PREVENT-19 vaccine trial and Study 307.
5 Investors Betting Big on Novavax (NVAX) Stock
NVAX stock is in focus as the company receives a recommendation from the Swiss health agency concerning its Nuvaxovid drug.
Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway
Today, investors in Novavax and NVAX stock are cheering the start of a major conference on vaccine tech, which Novavax is a part of.
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data.
A Shot of NVAX Stock Is NOT What Your Portfolio Needs
Even before Biden's 'pandemic is over' declaration, NVAX stock struggled due to weak demand for Novavax's Covid-19 shots.
